A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/<i>NRG1</i> gene
José Adélaı̈de(Centre de Recherche en Cancérologie de Marseille), Max Chaffanet(Centre National de la Recherche Scientifique), Charles Theillet(Centre National de la Recherche Scientifique), Christophe Ginestier(Inserm), Daniel Birnbaum(Hôpital Nord), Cornel Popovici(Inserm), Céline Basset(Inserm), Paul A. Edwards(University of Cambridge), Béatrice Orsetti(Centre National de la Recherche Scientifique), Huai-En Huang(University of Cambridge), Anne Murati(Inserm), Amber E. Alsop(The University of Melbourne), Céline Courtay-Cahen(Animal Health Trust), A Letessier(Inserm), Jocelyne Jacquemier(Centre de Recherche en Cancérologie de Marseille), Julien Mozziconacci(Groupe Francophone des Myélodysplasies)
Cited by 61
Related Papers
Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing
|Nature Genetics|2008|841
The ExAC browser: displaying reference data information from over 60 000 exomes
|Nucleic Acids Research|2016|832
Improving genetic diagnosis in Mendelian disease with transcriptome sequencing
|Science Translational Medicine|2017|809
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
|Journal of Clinical Investigation|2010|738